MedPath

Prospective Study of the Impact of Systemic Corticosteroid Use on Measures of Sleep Disordered Breathing

Completed
Conditions
Sleep Apnea
Registration Number
NCT01228695
Lead Sponsor
Rambam Health Care Campus
Brief Summary

Weight gain is both a significant risk factor for obstructive sleep apnea and a side-effect of long-term systemic steroids therapy.

This study aimed to investigate the impact of long-term systemic steroid treatment on sleep apnea.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • For inclusion, a scheduled therapy with a minimum daily dose of 10 mg prednisone (or equivalent) for at least 3 months was required
Exclusion Criteria
  • Patients younger than 18 years and those with known sleep apnea or other forms of sleep-disordered breathing were excluded

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
apnea-hypopnea index3 months
Secondary Outcome Measures
NameTimeMethod
sleep study variables3 months

apnea-hypopnea interval desaturation at the end of apnea interval snoring intensity

Trial Locations

Locations (1)

Rambam health care campus

🇮🇱

Haifa, Israel

Rambam health care campus
🇮🇱Haifa, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.